Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 4 June 1999:
Vol. 284. no. 5420, pp. 1594 - 1595
DOI: 10.1126/science.284.5420.1594b
Prev | Table of Contents | Next

News of the Week

ORGAN TRANSPLANTS:
New Drug Blocks Rejection in Monkeys

Gretchen Vogel

According to a report in the June issue of Nature Medicine, blocking a key immune system signal in monkeys for only a few months after a kidney transplant leads to long-term acceptance of the new organ--with no detectable side effects. The new drug is an antibody that binds to a protein called CD154, one of two signals that the immune system's T cells need to launch an attack against an invader. Although scientists caution that it's too soon to know if the monkeys have permanently accepted their new organs, transplant immunologists are very excited about the results, and human trials are now getting under way.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)